Susan G. Macdonald, Ph.D. has served as Vice President of Research and Development since August of 2016, having joined Aldeyra in August 2015 as Senior Director of Scientific Affairs. Dr. Macdonald has more than 25 years of experience in research and development, spanning several therapeutic areas, including inflammation and autoimmune disease, ophthalmology, oncology, and cardiovascular disease. Her expertise includes leading cross-functional discovery and development programs, alliance management, and developing strategies for projects and portfolios. Prior to joining Aldeyra, she held senior roles in R&D Strategy, Portfolio, and Project Management at Alexion Pharmaceuticals and Program Management at NKT Therapeutics. She has also served in a variety of roles at Archemix, ArQule, TEI Biosciences, and Onyx Pharmaceuticals, where, as a founding employee, she conducted research that enabled the discovery of sorafenib (Nexavar®). She received her undergraduate degree in biology from Hobart and William Smith Colleges and her Ph.D. in Physiology from the University of Massachusetts Medical School. She completed her postdoctoral training at Onyx Pharmaceuticals, during which she received a prestigious NIH National Research Service Award.